News
Keeping you up to date with the clinical research sector innovations and news
Industry news
- Sebela Pharmaceuticals Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results
- Boehringer and Click Therapeutics’ Investigational Prescription Digital Therapeutic CT-155 Meets Primary Endpoint in CONVOKE Study for Negative Symptoms in Schizophrenia
- Lilly's Oral GLP-1, Orforglipron, Delivers Weight Loss of Up To an Average of 27.3 lbs in First of Two Pivotal Phase 3 Trials in Adults with Obesity
- U.S. FDA Granted Fast Track Designation to Dizal’s Birelentinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain
- Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma
- Wearable technology to be offered to thousands with type 1 diabetes in UK
- NHS expands home-testing kits to detect bowel cancer earlier
- Novo Nordisk Foundation establishes new vaccine initiative worth $260m
- Key Parkinson’s protein could offer new potential targets for treatment
- BioMed X and Ono Pharmaceutical enter joint cancer research project
- Heart vests to identify those at high risk of sudden cardiac death
- Digital health collaboration to trial AI-powered X-rays for lung cancer detection
- Cognitive decline in early Alzheimer’s could stem from serotonin loss
- New filtering system to combat spread of infections in hospitals
- AstriVax awarded €3m to develop therapeutic vaccine for hepatitis B
- Sano Genetics launches ‘Light the Way’ programme for MND
- PharmaKure and UiTM enter research partnership for Alzheimer’s disease
- Study confirms safety of new flow-diverting stent to treat brain aneurysms
- ACSR to use digitised pathology for HIV-associated malignancies
- New study finds heathy cells ‘push’ cancer cells to resist treatment
- Babies born early have an increased risk of developmental disorders
- UKHSA urges individuals from ethnic minority groups to get vaccinated
- NHS rolls out online GP registration to over 2,000 practices
- Cambridge researchers redesign future mRNA therapeutics
- BioMed X launches call for applications in autoimmune disease research
Tailored Clinical Research Solutions
Holborn Gate,
330 High Holborn
London
WC1V 7QH
